[{"address1": "11750 Sorrento Valley Road", "address2": "Suite 200", "city": "San Diego", "state": "CA", "zip": "92121", "country": "United States", "phone": "979 446 0027", "website": "https://ibioinc.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "iBio, Inc., a preclinical stage biotechnology company, engages in the development of artificial intelligence (AI) antibodies solutions for cancer, and other diseases. The company's technology platforms include EngageTx that provides improved CD3 T-cell engager antibody panel; ShieldTx, an antibody masking technology that enables the creation of conditionally activated antibodies; StableHu, an AI antibody-optimizing technology; and AI epitope steering technology that guides antibodies against the desired regions of the target protein. Its product pipelines for cardiometabolic disease area include IBIO-101, an anti-CD25 Mab that binds and depletes immunosuppressive regulatory treg cells to inhibit the growth of solid tumors; CCR8, an antibody that enhance the body's immune response against cancer cells; and trophoblast cell surface antigen 2, a monoclonal antibodies, as well as MUC16 and Target 5 antibodies. In addition, the company is developing EGFRvIII, an antibody therapeutics that targets EGFRvIII protein with the aim to address these cancer types without affecting healthy cells. It has a collaboration agreement with AstralBio to discover and develop novel antibodies for obesity and other cardiometabolic diseases. iBio, Inc. was incorporated in 2008 and is headquartered in San Diego, California.", "fullTimeEmployees": 16, "companyOfficers": [{"maxAge": 1, "name": "Dr. Martin B. Brenner D.V.M., Ph.D.", "age": 54, "title": "CEO, Chief Scientific Officer & Director", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 753000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Felipe  Duran", "age": 45, "title": "Chief Financial Officer", "yearBorn": 1979, "fiscalYear": 2024, "totalPay": 513224, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Marc  Banjak J.D.", "title": "Chief Legal Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kristi  Sarno", "title": "Senior VP of Business Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 7, "compensationRisk": 9, "shareHolderRightsRisk": 4, "overallRisk": 7, "governanceEpochDate": 1738368000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 3.76, "open": 3.79, "dayLow": 3.7, "dayHigh": 5.2, "regularMarketPreviousClose": 3.76, "regularMarketOpen": 3.79, "regularMarketDayLow": 3.7, "regularMarketDayHigh": 5.2, "payoutRatio": 0.0, "beta": -3.288, "trailingPE": 3.8846157, "forwardPE": -3.0792685, "volume": 4913544, "regularMarketVolume": 4913544, "averageVolume": 248310, "averageVolume10days": 519560, "averageDailyVolume10Day": 519560, "bid": 0.0, "ask": 0.0, "bidSize": 8, "askSize": 14, "marketCap": 49867136, "fiftyTwoWeekLow": 1.05, "fiftyTwoWeekHigh": 5.2, "priceToSalesTrailing12Months": 132.97903, "fiftyDayAverage": 2.9476, "twoHundredDayAverage": 2.42315, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 47605112, "profitMargins": 0.0, "floatShares": 8599460, "sharesOutstanding": 9874680, "sharesShort": 454207, "sharesShortPriorMonth": 241998, "sharesShortPreviousMonthDate": 1736899200, "dateShortInterest": 1739491200, "sharesPercentSharesOut": 0.046, "heldPercentInsiders": 0.07205, "heldPercentInstitutions": 0.26650998, "shortRatio": 1.44, "shortPercentOfFloat": 0.0461, "impliedSharesOutstanding": 9874680, "bookValue": 1.516, "priceToBook": 3.3311346, "lastFiscalYearEnd": 1719705600, "nextFiscalYearEnd": 1751241600, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -14234000, "trailingEps": 1.3, "forwardEps": -1.64, "lastSplitFactor": "1:20", "lastSplitDate": 1701216000, "enterpriseToRevenue": 126.947, "enterpriseToEbitda": -3.236, "52WeekChange": 2.032258, "SandP52WeekChange": 0.15942514, "quoteType": "EQUITY", "currentPrice": 5.05, "targetHighPrice": 5.96, "targetLowPrice": 3.6, "targetMeanPrice": 4.78, "targetMedianPrice": 4.78, "recommendationKey": "none", "numberOfAnalystOpinions": 2, "totalCash": 7015000, "totalCashPerShare": 0.71, "ebitda": -14713000, "totalDebt": 4753000, "quickRatio": 1.492, "currentRatio": 1.759, "totalRevenue": 375000, "debtToEquity": 34.207, "revenuePerShare": 0.05, "returnOnAssets": -0.34907, "returnOnEquity": -1.23281, "grossProfits": 375000, "freeCashflow": 4950750, "operatingCashflow": -16092000, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": -22.095, "financialCurrency": "USD", "symbol": "IBIO", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "exchange": "ASE", "messageBoardId": "finmb_33000", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "marketState": "PREPRE", "longName": "iBio, Inc.", "shortName": "iBio, Inc.", "regularMarketChangePercent": 34.3085, "regularMarketPrice": 5.05, "corporateActions": [], "postMarketTime": 1740704389, "regularMarketTime": 1740690000, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1219152600000, "postMarketChangePercent": -1.98021, "postMarketPrice": 4.95, "postMarketChange": -0.1, "regularMarketChange": 1.29, "regularMarketDayRange": "3.7 - 5.2", "fullExchangeName": "NYSE American", "averageDailyVolume3Month": 248310, "fiftyTwoWeekLowChange": 4.0, "fiftyTwoWeekLowChangePercent": 3.809524, "fiftyTwoWeekRange": "1.05 - 5.2", "fiftyTwoWeekHighChange": -0.14999962, "fiftyTwoWeekHighChangePercent": -0.028846081, "fiftyTwoWeekChangePercent": 203.2258, "dividendDate": 1528675200, "earningsTimestamp": 1739221500, "earningsTimestampStart": 1747047540, "earningsTimestampEnd": 1747396800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": 1.3, "epsForward": -1.64, "epsCurrentYear": -1.59, "priceEpsCurrentYear": -3.1761007, "fiftyDayAverageChange": 2.1024003, "fiftyDayAverageChangePercent": 0.7132584, "twoHundredDayAverageChange": 2.6268501, "twoHundredDayAverageChangePercent": 1.0840641, "displayName": "iBio", "trailingPegRatio": null, "__fetch_time": "2025-02-28"}]